Laird Norton Wetherby Wealth Management’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $738K | Buy |
+2,860
| New | +$738K | 0.03% | 449 |
|
|
2024
Q4 | $761K | Sell |
3,326
-270
| -8% | -$61.7K | 0.04% | 408 |
|
|
2024
Q3 | $878K | Sell |
3,596
-109
| -3% | -$26.6K | 0.04% | 388 |
|
|
2024
Q2 | $709K | Sell |
3,705
-61
| -2% | -$11.7K | 0.03% | 432 |
|
|
2024
Q1 | $746K | Buy |
3,766
+27
| +0.7% | +$5.35K | 0.04% | 430 |
|
|
2023
Q4 | $643K | Buy |
3,739
+1,523
| +69% | +$262K | 0.03% | 456 |
|
|
2023
Q3 | $328K | Sell |
2,216
-190
| -8% | -$28.1K | 0.02% | 659 |
|
|
2023
Q2 | $526K | Sell |
2,406
-467
| -16% | -$102K | 0.03% | 519 |
|
|
2023
Q1 | $629K | Buy |
2,873
+22
| +0.8% | +$4.82K | 0.04% | 457 |
|
|
2022
Q4 | $593K | Sell |
2,851
-497
| -15% | -$103K | 0.04% | 466 |
|
|
2022
Q3 | $731K | Buy |
3,348
+562
| +20% | +$123K | 0.05% | 360 |
|
|
2022
Q2 | $584K | Buy |
2,786
+292
| +12% | +$61.2K | 0.04% | 453 |
|
|
2022
Q1 | $605K | Buy |
2,494
+147
| +6% | +$35.7K | 0.03% | 455 |
|
|
2021
Q4 | $611K | Buy |
2,347
+36
| +2% | +$9.37K | 0.03% | 450 |
|
|
2021
Q3 | $609K | Buy |
2,311
+25
| +1% | +$6.59K | 0.04% | 437 |
|
|
2021
Q2 | $564K | Buy |
2,286
+22
| +1% | +$5.43K | 0.03% | 466 |
|
|
2021
Q1 | $439K | Sell |
2,264
-61
| -3% | -$11.8K | 0.03% | 478 |
|
|
2020
Q4 | $494K | Sell |
2,325
-24
| -1% | -$5.1K | 0.03% | 462 |
|
|
2020
Q3 | $403K | Buy |
2,349
+8
| +0.3% | +$1.37K | 0.04% | 427 |
|
|
2020
Q2 | $449K | Sell |
2,341
-173
| -7% | -$33.2K | 0.04% | 384 |
|
|
2020
Q1 | $370K | Buy |
2,514
+425
| +20% | +$62.6K | 0.04% | 392 |
|
|
2019
Q4 | $324K | Buy |
2,089
+48
| +2% | +$7.45K | 0.03% | 514 |
|
|
2019
Q3 | $276K | Buy |
2,041
+310
| +18% | +$41.9K | 0.03% | 569 |
|
|
2019
Q2 | $211K | Buy |
+1,731
| New | +$211K | 0.02% | 632 |
|